View in EDS HTML Full Text PDF Full Text

Mixture design optimization of salvianolic acid B, tanshinone IIA, butein, and formononetin from Salvia miltiorrhiza and Dalbergia odorifera for myocardial infarction.

Saved in:
Bibliographic Details
Title: Mixture design optimization of salvianolic acid B, tanshinone IIA, butein, and formononetin from Salvia miltiorrhiza and Dalbergia odorifera for myocardial infarction.
Authors: Li W; College of Life Sciences, Northwest University, Xi'an, China.; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Liu K; College of Life Sciences, Northwest University, Xi'an, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Liu C; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.; State Key Laboratory of Flexible Electronics (LOFE) & Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi'an, China., Dai Q; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Yao H; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Wang H; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Ding Z; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Cao X; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China., Wei P; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; National Drug Clinical Trial Institute, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, China., Xi M; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.; National Drug Clinical Trial Institute, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, China., Zhang S; College of Life Sciences, Northwest University, Xi'an, China.; School of Pharmacy, Air Force Medical University, Xi'an, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Jun 25; Vol. 17, pp. 1783969. Date of Electronic Publication: 2026 Jun 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42428511
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mixture design optimization of salvianolic acid B, tanshinone IIA, butein, and formononetin from Salvia miltiorrhiza and Dalbergia odorifera for myocardial infarction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; College of Life Sciences, Northwest University, Xi'an, China.; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; College of Life Sciences, Northwest University, Xi'an, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.; State Key Laboratory of Flexible Electronics (LOFE) & Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Dai+Q%22">Dai Q</searchLink>; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Yao+H%22">Yao H</searchLink>; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Ding+Z%22">Ding Z</searchLink>; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Cao+X%22">Cao X</searchLink>; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Wei+P%22">Wei P</searchLink>; College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.; National Drug Clinical Trial Institute, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, China.<br /><searchLink fieldCode="AU" term="%22Xi+M%22">Xi M</searchLink>; TANK Medicinal Biology Institute of Xi'an, Xi'an, China.; National Drug Clinical Trial Institute, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, China.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; College of Life Sciences, Northwest University, Xi'an, China.; School of Pharmacy, Air Force Medical University, Xi'an, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 Jun 25; Vol. 17, pp. 1783969. <i>Date of Electronic Publication: </i>2026 Jun 25 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42428511
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2026.1783969
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1783969
    Titles:
      – TitleFull: Mixture design optimization of salvianolic acid B, tanshinone IIA, butein, and formononetin from Salvia miltiorrhiza and Dalbergia odorifera for myocardial infarction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Liu K
      – PersonEntity:
          Name:
            NameFull: Liu C
      – PersonEntity:
          Name:
            NameFull: Dai Q
      – PersonEntity:
          Name:
            NameFull: Yao H
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Ding Z
      – PersonEntity:
          Name:
            NameFull: Cao X
      – PersonEntity:
          Name:
            NameFull: Wei P
      – PersonEntity:
          Name:
            NameFull: Xi M
      – PersonEntity:
          Name:
            NameFull: Zhang S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 06
              Text: 2026 Jun 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1